Exosome therapy for childhood autism study
Part of Mental health clinical trials.
This trial tests if exosomes from stem cells can help children with autism who haven't improved enough with standard behavioral therapy. It aims to see if this treatment is safe and effective for reducing autism symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child has a confirmed diagnosis of autism spectrum disorder (ASD) using standard criteria.
- Child has not shown much improvement after at least 3 months of standard behavioral therapy.
- Child scores 30 or higher on a test that measures autism severity (CARS2), meaning mild-to-moderate or more severe autism.
- Child is between 3 and 7 years old, including ages 3 and 7.
- Parent or legal guardian agrees to the study and signs a consent form.
- Child is willing to undergo all tests, treatments, and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This study will test whether breathing a special gas called xenon can help reduce autism symptoms in children and teens. It's an early-stage trial that aims to see if the treatment is safe and if it may improve social and behavioral challenges.
This trial tests whether stem cells from donated umbilical cord tissue can help children with autism. It is for children aged 4–14 who weigh at least 10 kg and are otherwise healthy.
This study tests whether a special type of stem cell (mesenchymal stem cells) can help improve symptoms of autism. It's an early-phase trial, meaning the main goal is to see if the treatment is safe and to gather initial information on how well it might work.
This study tests whether a nasal spray containing tiny particles from dental stem cells (called exosomes) is safe and can help with 'negative symptoms' of schizophrenia, such as lack of motivation or emotion. It's a very early-stage trial for people who haven't gotten enough relief from standard treatments.
Hear when a new Prospective Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.